Activity of ceftolozane-tazobactam and comparators when tested against bacterial surveillance isolates collected from patients at risk of infections caused by resistant gram-negative pathogens.
Sign Up to like & getrecommendations! Published in 2020 at "Diagnostic microbiology and infectious disease"
DOI: 10.1016/j.diagmicrobio.2020.115101
Abstract: Ceftolozane-tazobactam is an antipseudomonal cephalosporin combined with a β-lactamase inhibitor. Ceftolozane-tazobactam has been approved for treatment of complicated urinary tract infections and acute pyelonephritis, for complicated intra-abdominal infections (with metronidazole) in adults, and for hospital-acquired… read more here.
Keywords: ceftolozane; gram negative; infections caused; ceftolozane tazobactam ... See more keywords
Risk of infections in psoriasis: assessment and challenges in daily management
Sign Up to like & getrecommendations! Published in 2021 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2021.1997592
Abstract: ABSTRACT Introduction In daily practice management of psoriasis, evaluation of risk factors for infections is having a growing influence. Indeed, in psoriatic patients, risk of infections may be due to psoriasis itself, immunomodulatory therapy, and… read more here.
Keywords: risk infections; management; infections psoriasis; risk ... See more keywords
Increased risk of infections in pediatric Fontan patients after heart transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Transplantation"
DOI: 10.1111/petr.14421
Abstract: Infectious complications are a major cause of morbidity and mortality after HT. Fontan patients may be more susceptible to post‐HT infections. read more here.
Keywords: fontan patients; increased risk; transplantation increased; infections pediatric ... See more keywords
Risk of infections and mortality in Danish patients with cancer diagnosed with bone metastases: a population-based cohort study
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-049831
Abstract: Objectives Risk of infections in patients with solid cancers and bone metastases (BM) and the subsequent impact on prognosis is unclear. We examined the risk of infections among patients with cancer diagnosed with BM and… read more here.
Keywords: cancer; risk infections; bone metastases; infections mortality ... See more keywords
Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections.
Sign Up to like & getrecommendations! Published in 2022 at "Immunotherapy"
DOI: 10.2217/imt-2022-0142
Abstract: Aim: Patients with secondary immunodeficiency (SID) are at increased risk of infections and may be treated with immunoglobulin replacement therapy (IgRT). Despite growing efficacy evidence for IgRT in infection prevention in SID, treatment guidelines are… read more here.
Keywords: patients risk; igpro10; secondary immunodeficiency; risk infections ... See more keywords
Evaluating Ethnic Variations in the Risk of Infections in People With Prediabetes and Type 2 Diabetes: A Matched Cohort Study
Sign Up to like & getrecommendations! Published in 2023 at "Diabetes Care"
DOI: 10.2337/dc22-2394
Abstract: OBJECTIVE People living with type 2 diabetes (T2D) are at higher infection risk, but it is unknown how this risk varies by ethnicity or whether the risk is similarly observed in people with nondiabetic hyperglycemia… read more here.
Keywords: infection; risk; type diabetes; risk infections ... See more keywords
Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.945626
Abstract: Introduction Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease in developed countries, with its incidence growing parallel to the epidemics of obesity and type 2 diabetes mellitus (T2DM). Sodium-glucose co-transporter-2 inhibitors… read more here.
Keywords: sglt2i; type diabetes; risk infections; nafld patients ... See more keywords
Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies
Sign Up to like & getrecommendations! Published in 2023 at "Life"
DOI: 10.3390/life13061272
Abstract: Concurrent infections in hematological malignancies (HM) are major contributors to adverse clinical outcomes, including prolonged hospitalization and reduced life expectancy. Individuals diagnosed with HM are particularly susceptible to infectious pathogens due to immunosuppression, which can… read more here.
Keywords: targeted therapies; infectious complications; secondary use; infections secondary ... See more keywords